Physician profile
Brett E Casey
NPI 1083627053
$2,259.48
in general payments reported to CMS, 2019-2025
36 companies · $300 in 2025
The $300 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2020: $159 · 2021: $433 · 2022: $233 · 2023: $247 · 2024: $323 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $869.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $200.83 | 2019-2023 | |
| Abbott Laboratories | $160.38 | 2024-2025 | Eterna, Proclaim |
| Amgen INC. | $156.30 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $141.35 | 2019-2022 | |
| Linvatec Corporation | $132.29 | 2023 | Biobrace 23mm |
| Smith+Nephew, INC. | $132.26 | 2019-2022 | |
| Depuy Synthes Sales INC. | $132.08 | 2024 | Va-Lcp, Na |
| Acumed LLC | $125.14 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $115.60 | 2019-2025 | Exparel, Iovera, Zilretta |
| Si-Bone, INC. | $97.40 | 2019-2024 | |
| Stryker Corporation | $85.63 | 2019-2025 | Aequalis Perform Reversed |
| Fidia Pharma USA INC. | $82.33 | 2021-2024 | Hyalgan, Hymovis, Triluron |
| Life Spine, INC. | $77.39 | 2022 | |
| Ortho Development Corporation | $61.50 | 2019 | |
| Bioventus LLC | $51.34 | 2019-2024 | Durolane |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $46.53 | 2019-2021 | |
| Innovation Technologies INC | $45.25 | 2024-2025 | Irrisept |
| Horizon Therapeutics Plc | $41.76 | 2019 | |
| Arbor Pharmaceuticals, INC. | $41.55 | 2019-2021 | |
| Cerapedics INC. | $38.98 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Azurity Pharmaceuticals, INC. | $31.36 | 2023 | Horizant |
| Ermi LLC | $31.05 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $28.92 | 2019 | |
| Vericel Corporation | $28.09 | 2020-2022 | |
| Pfizer INC. | $23.21 | 2019-2020 | |
| Convatec INC. | $18.08 | 2024 | |
| Medtronic, INC. | $17.88 | 2024 | Invos |
| Tactile Systems Technology INC | $15.88 | 2021 | |
| Abbvie INC. | $14.57 | 2022 | |
| Baudax Bio INC. | $13.57 | 2021 | |
| Melinta Therapeutics, LLC | $13.51 | 2021 | |
| Mallinckrodt Enterprises LLC | $13.35 | 2019 | |
| Pacira Therapeutics, INC. | $13.21 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.75 | 2022 | |
| Heraeus Medical, LLC. | $10.16 | 2019 | |
| Sonex Health, INC. | $8.00 | 2024 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Casey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.